Human Vaccine Adjuvants Market Scope And Analysis

  • Report Code : TIPRE00020517
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 199
Buy Now

Human Vaccine Adjuvants Market Report Scope 2021 to 2031

Buy Now

Human Vaccine Adjuvants Market Report Human Vaccine Adjuvants Market Size and Share Human Vaccine Adjuvants Market Scope and Analysis

Human Vaccine Adjuvants Market Report Scope

Report Attribute Details
Market size in 2022 US$ 1,571.41 Million
Market Size by 2030 US$ 4,489.23 Million
Global CAGR (2022 - 2030) 14.0%
Historical Data 2020-2021
Forecast period 2022-2030
Segments Covered By Type
  • Particulate Adjuvant
  • Emulsion Adjuvant
  • Combination Adjuvant
By Application
  • Influenza
  • Hepatitis
  • Human papilloma virus
By End User
  • Pharmaceutical and Biotechnology Companies
  • CMOs and CROs
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Novartis AG
  • Dynavax Technologies Corp
  • CSL Ltd
  • SEPPIC SA
  • SPI Pharma Inc
  • Hawaii Biotech Inc
  • Croda International Plc
  • Novavax Inc
  • Phibro Animal Health Corp
  • Creative Biolabs Inc
    		•